Tiotropium Bromide And Olodaterol has 8 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Drugs That Prolong Qtc Interval, Monoamine Oxidase Inhibitors (Maois), Nonselective Beta-Adrenergic Antagonists. Patients taking Tiotropium Bromide And Olodaterol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 8
- Major
- 3
- Moderate
- 4
Major (3)
- Tiotropium Bromide And Olodaterol + Drugs That Prolong Qtc Interval— QTc-prolonging drugs may potentiate cardiovascular effects and increase risk of ventricular arrhythmias. Use with extrem…
- Tiotropium Bromide And Olodaterol + Monoamine Oxidase Inhibitors (Maois)— MAO inhibitors may potentiate the action of adrenergic agonists on the cardiovascular system. Use with extreme caution.
- Tiotropium Bromide And Olodaterol + Nonselective Beta-Adrenergic Antagonists— Beta-blockers may decrease effectiveness of olodaterol and produce severe bronchospasm in COPD patients. Use with cautio…
Moderate (4)
- Tiotropium Bromide And Olodaterol + Diuretics— Diuretics may potentiate hypokalemia or ECG changes when used with olodaterol. Use with caution.
- Tiotropium Bromide And Olodaterol + Potassium Supplements— Non-potassium sparing diuretics may result in ECG changes and hypokalemia that can be worsened by olodaterol. Caution ad…
- Tiotropium Bromide And Olodaterol + Topical Steroids— Steroids may potentiate hypokalemia or ECG changes when used with olodaterol. Use with caution.
- Tiotropium Bromide And Olodaterol + Xanthine Derivatives— Xanthine derivatives may potentiate hypokalemia or ECG changes when used with olodaterol. Use with caution.